Hepatitis B Prevention research, articles, guidelines & medical evidence database search.
Access the latest scientific research and medical evidence related to Hepatitis B Prevention treatment, diagnosis and symptoms, quickly and easily with doctorAsyou.
Designed by medical professionals, for medical professionals, with doctorAsyou you can visualize research in a unique evidence dashboard. You can also export, save and sort results.
Sign up for free for full access.
All Pubmed data courtesy of the U.S. National Library of Medicine. Library last updated 19 December 2020.
Clinical trials databases last updated 1 December 2020 (clinicaltrials.gov) and 1 December 2020 (ictrp)
Sort by
Date
Institutional score
Impact
Patients
List order
Sort
Categories
Studies
2405 Unclassified
2044 Early Trials
1638 Reviews
1268 Advanced Trials
1147 Research
930 Other Trials
144 Case Reports
59 Meta-Analysis
Guidelines
108 Guidelines
33 Consensuses
6 Cochrane
Congresses
638 Abstracts
Research
Prevention of overfitting in cryo-EM structure determination.
Scheres Sjors H W, Chen Shaoxia
Nature methods Vol 9(9)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 01 Sep 2012
Research
Viral hepatitis, type B. Studies on natural history and prevention re-examined.
Krugman S, Overby L R, Mushahwar I K, Ling C M, Frösner G G ...
The New England journal of medicine Vol 300(3)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 18 Jan 1979
Research
Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention.
Krugman S, Giles J P
The New England journal of medicine Vol 288(15)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 12 Apr 1973
Research
Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Engels Eric A, Cho Eo Rin, Jee Sun Ha
The Lancet. Oncology Vol 11(9)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 01 Sep 2010
Research
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.
Lupberger Joachim, Zeisel Mirjam B, Xiao Fei, Thumann Christine, Fofana Isabel ...
Nature medicine Vol 17(5)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 01 May 2011
Research
NF-kappaB functions as a tumour promoter in inflammation-associated cancer.
Pikarsky Eli, Porat Rinnat M, Stein Ilan, Abramovitch Rinat, Amit Sharon ...
Nature Vol 431(7007)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 23 Sep 2004
Research
Hepatitis B, hepatocellular carcinoma, and strategies for prevention.
Arthur M J, Hall A J, Wright R
Lancet (London, England) Vol 1(8377)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 17 Mar 1984
Research
Measurement of anti-GOR antibodies in prevention of post-transfusion non-A, non-B hepatitis.
Yoshizawa H, Nojiri N, Takahashi K
Lancet (London, England) Vol 337(8732)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 05 Jan 1991
Research
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.
Ross R K, Yuan J M, Yu M C, Wogan G N, Qian G S ...
Lancet (London, England) Vol 339(8799)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 18 Apr 1992
Research
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Petersen Joerg, Dandri Maura, Mier Walter, Lütgehetmann Marc, Volz Tassilo ...
Nature biotechnology Vol 26(3)
ReadAdd to library
Add to library
Select a folder
Create a new folder +
Cancel
Date 01 Mar 2008
View
per page
Page
1
2
3
4
5
6
7
8
9
10
Last
